Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood test, Maternal exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (One drink a week prior to pregnancy). Concomitant products included SPIRONOLACTONE from 25-Mar-2019 to 04-Mar-2021 for Acne, CETIRIZINE HYDROCHLORIDE (CETRIZINE) from 25-Mar-2020 to 04-Oct-2020 for Allergy, DOCUSATE from 15-Feb-2021 to an unknown date for Constipation, FAMOTIDINE for Heartburn, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnant, TRIVITE from 04-Nov-2020 to an unknown date for Vitamin supplementation.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 05-Sep-2020 and the estimated date of delivery was 12-Jun-2021. On 31-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy. The vaginal delivery occurred , which was reported as Full-term. For neonate 1, the birth weight was 1501 grams (3lbs 5oz) with an APGAR score of 8 and 9 at (1, 5 minutes). The outcome was reported as Term Birth w/o Complications. Female fetus was delivered at 41+2 weeks of gestation with 53.3 cm length and 34 cm head circumference. There was no fetal abnormalities on delivery and no infant abnormalities at 1 month post partum. On 31-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Oct-2020, Pregnancy test: positive (Positive) Positive. On 05-Nov-2020, Ultrasound foetal: normal (normal) Normal. On 03-Dec-2020, Blood test: normal (normal) Normal. On 03-Dec-2020, Ultrasound foetal: normal (normal) Normal. On 22-Apr-2021, Ultrasound foetal: normal (normal) normal. On 03-Nov-2021, Blood glucose: normal (Negative) Normal-negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.   Most recent FOLLOW-UP information incorporated above includes: On 08-Aug-2021: Follow-up received on 08-aug-2021 and contains delivery information and concomitant medication information.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.